Neurogene (NGNE) Net Income towards Common Stockholders (2018 - 2025)
Historic Net Income towards Common Stockholders for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.
- Neurogene's Net Income towards Common Stockholders fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
- As of Q3 2025, Neurogene's Net Income towards Common Stockholders stood at -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
- In the past 5 years, Neurogene's Net Income towards Common Stockholders registered a high of -$11.9 million during Q2 2023, and its lowest value of -$23.2 million during Q2 2025.
- For the 3-year period, Neurogene's Net Income towards Common Stockholders averaged around -$17.8 million, with its median value being -$18.6 million (2024).
- In the last 5 years, Neurogene's Net Income towards Common Stockholders tumbled by 5713.92% in 2024 and then crashed by 365.48% in 2025.
- Neurogene's Net Income towards Common Stockholders (Quarter) stood at -$14.0 million in 2023, then plummeted by 40.71% to -$19.7 million in 2024, then dropped by 7.35% to -$21.1 million in 2025.
- Its last three reported values are -$21.1 million in Q3 2025, -$23.2 million for Q2 2025, and -$22.8 million during Q1 2025.